(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 Ibrutinib Intermediate Purity >99.0% (GC) Avanoa Ata

(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 Ibrutinib Vaeluaga Mama >99.0% (GC)

Fa'amatalaga Puupuu:

Igoa Vailaau: (S)-1-Boc-3-Hydroxypiperidine

CAS: 143900-44-1

Amio mama: >99.0% (GC)

Vailaau mama: >99.0% (GC)

Fa'aaliga: Pa'u Pa'epa'e po'o tioata

Intermediate of Ibrutinib (CAS: 936563-96-1)

Tulaga Maualuga, Gaosiga Fa'apisinisi

E-Mail: alvin@ruifuchem.com

Auina imeli ia matou

Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Ibrutinib Fesoʻotaʻi Faʻatasi:
(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1
4-Phenoxyphenylboronic Acid CAS 51067-38-0
Ibrutinib Intermediate N-2 CAS 330786-24-8
Ibrutinib Intermediate N-3 CAS 330792-70-6
Ibrutinib CAS 936563-96-1

Meatotino tau vailaau:

Igoa Vailaau	(S)-1-Boc-3-Hydroxypiperidine
Synonyms	(S)-1-(tert-Butoxycarbonyl)-3-Hydroxypiperidine;(S)-1-Boc-3-Piperidinol
Numera CAS	143900-44-1
CAT Numera	RF-CC299
Tulaga Fa'asoa	I totonu o faʻatauga, Gaosi gaosiga 20 Tone/Masina
Fuafua mole	C10H19NO3
Molecular Weight	201.27
Lisi Lisi	52.0~56.0 ℃
Solubility	Solu i le Methanol
Ta'amilosaga Fa'apitoa [a]20/D	+9.0°~+11.0° (C=1 ile Chloroform)
Fa'ailoga	Ruifu Chemical

Fa'amatalaga:

Aitema	Fa'amatalaga
Fa'aaliga	Pa'u Pa'epa'e po'o tioata
Chiral Mama	>99.5% (GC)
Vailaau Mama	>99.5% (GC)
Vai (KF)	≤0.50%
Methanol (GC)	≤50ppm
Ethanol (GC)	≤50ppm
DCM (GC)	≤500ppm
3-Hydroxypiperidine	≤0.10%
3-Hydroxypyridine	≤0.20%
1-Boc-3-Piperidone	≤0.10%
1-Boc-4-Hydroxypiperidine	≤0.10%
1.96 RRT	≤0.20%
So'o se mea le mama e le o ta'ua	≤0.10%
Tulaga Su'ega	Pisinisi Tulaga
Fa'aoga	Vailaau Fa'atekonolosi;Chiral Compounds

Paket & Teuina:

afifi: Fagu, Ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau.

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu.

Tulaga lelei:

FAQ:

Talosaga:

(S) -1-Boc-3-Hydroxypiperidine (CAS: 143900-44-1) o se mea taua tele mo le tuʻufaʻatasia o Ibrutinib (CAS: 936563-96-1).Ibrutinib o se ituaiga o Bruton tyrosine kinase (BTK) inhibitor, e mafai ona faʻaaogaina mo le togafitia o le leukemia lymphocytic masani (CLL) ma le lymphoma sela (MCL).O le MCL ma le CLL e a'afia i le B-cell non-Hodgkin's lymphoma, lea e faigata ona fofo ma faigofie ona toe tupu.Ole fa'ama'i fa'ama'i masani e leai se fa'atatau, e masani ona tupu ile 3 pe 4 fa'alavelave leaga.Ibrutinib ma B lymphocytes e mafai ona taulaʻi i le BTK lea e manaʻomia mo le faʻavaeina, faʻavasegaina, ma le tuʻuina atu o faʻamatalaga, faʻalavelaveina le gaioiga o le BTK e le mafai ona toe faʻafoʻisia, ma faʻalavelaveina le tuputupu aʻe o le tumo ma le ola lelei.Ibrutinib e mafai ona vave faʻafefe pe a uma le tautala tautala, i le taimi o le 1 ~ 2h e oʻo atu i le maualuga o le toto maualuga, o aʻafiaga leaga e tasi pe lua, o le mea lea, o le a avea Ibrutinib ma se filifiliga fou o togafitiga o CLL ma MCL.